The clinical efficacy of resection with spleen preservation or containing for benign and borderline tumor in pancreatic tail
10.3969/j.issn.1005-6483.2018.02.014
- VernacularTitle:保脾和切脾的胰体尾良性和交界性肿瘤切除术临床疗效比较
- Author:
Honglin ZHANG
1
;
Fulin CHENG
Author Information
1. 437600,湖北省通山县人民医院外四科
- Keywords:
spleen preserving distal pancreatectomy;
complications;
prognosis
- From:
Journal of Clinical Surgery
2018;26(2):124-126
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the clinical efficacy of the distal pancreatectomy with spleen preservation and the splenectomy in pancreatic tail for the treatment of benign and borderline tumor. Methods A total of 37 patients with pancreatic benign and borderline tumor from January 2012 to De-cember 2014 in our hospital were treated by laparoscopic surgery.Eleven cases were received distal pan-createctomy with spleen preservation(spleen preserving group)and 26 cases were received resection of pancreatic tail with spleen containing(splenectomy group).Results The operation time of spleen preser-ving group and splenectomy group were(165.34 ± 12.25)mins and(170.72 ± 14.37)mins(P>0.05). The blood loss in the preserving spleen group(108.52 ± 13.11)ml was significantly less than that in the splenectomy group(186.25 ± 17.43)ml(P <0.05).The hospitalization time of the preserving spleen group(10.16 ± 2.11)d was significantly shorter than that of the splenectomy group(12.78 ± 2.78)d(P<0.05).The use of Octreotide in the preserving spleen group(11.45 ± 3.75)mg was significantly less than that in the splenectomy group(16.75 ± 5.75)mg(P <0.01).All patients were followed up for three years.The disease free survival(DFS)in the spleen preserving group was higher than that in the splenecto-my group(100% vs.88.46%)with P<0.05.Conclusion The distal pancreatectomy with spleen preser-vation is safe,effective and suitable for pancreatic benign and borderline tumors.
